Sandu Pharmaceuticals Ltd

Wed 2/09/2026,16:1:0 | BSE : SANDUPHQ

₹38.05-0.27 (-0.70%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 38.49

Previous Close

₹ 38.32

Volume

3288

Mkt Cap ( ₹ Cr)

₹ 36.76

High

₹ 38.49

Low

₹ 36.66

52 Week High

₹ 50.50

52 Week Low

₹ 30.00

Book Value Per Share

₹ 45.44

Dividend Yield

₹ 2.60

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Sandu Pharmaceuticals Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sandu Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sandu Pharma. - Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Regis

    19 Aug 2026, 5:42PM Letters to shareholders on annual report weblink whose email ids are not registered with the company/RTA

  • Sandu Pharma. - Reg. 34 (1) Annual Report.

    19 Aug 2026, 5:39PM 41st Annual Report of Sandu Pharmaceuticals Limited

  • Sandu Pharma. - Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing ('VC')/ Othe

    19 Aug 2026, 5:33PM Intimation about Annual General Meeting

  • Sandu Pharma. has declared 10% Final dividend for the financial year March 2026

    13 Aug 2026, 6:21PM Sandu Pharmaceuticals Ltd. on Tuesday, 05 May 2026, has announced Final dividend of 10 percent on Equity Share, to its shareholders holding shares on

  • Sandu Pharma. - Approval Of Material Related Party Transactions Subject To Approval Of Shareholders

    11 Aug 2026, 6:42PM approval of material related party transactions subject to approval of shareholder

  • Sandu Pharma. - Statement Of Deviation And Utilisation Of Funds For Q Ended 30.06.2026

    11 Aug 2026, 6:39PM statement of deviation and utlisation of funds for q ended 30.06.2026

  • Sandu Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    11 Aug 2026, 6:16PM Appointment of M/s Dave & Dave Chartered Accountant as statutory auditor subject to approval of the shareholder

  • Sandu Pharma. - Intimation About The Date Of The Annual General Meeting

    11 Aug 2026, 6:07PM Intimation about the date of the annual General Meeting

  • Sandu Pharma. - Intimation About The Record Date

    11 Aug 2026, 6:05PM Intimation about the Record date

  • Sandu Pharma. - Intimation About Book Closure For AGM

    11 Aug 2026, 6:03PM Intimation about Book closure for AGM

  • Sandu Pharma. - Outcome And Results Of The Board Meeting Dated 11.08.2026 Was Submitted On Time But Inadvertently No Digital

    11 Aug 2026, 6:00PM Outcome and results of the Board Meeting dated 11.08.2026

  • Sandu Pharma. - Unaudited Financials For Q Ended 30.06.2026

    11 Aug 2026, 5:46PM Unaudited Financials For ended 30.06.2026

  • Sandu Pharma. - Outcome Of The Board Meeting

    11 Aug 2026, 5:40PM Outcome of the Board Meeting 11.08.2026

  • Sandu Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.08.2026

    11 Aug 2026, 5:25PM Outcome of the Board Meeting

  • Sandu Pharma. - Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Compan

    3 Aug 2026, 2:52PM Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to conside

  • Sandu Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    16 Jul 2026, 1:50PM As of June 2026, 37.79% is owned by Indian Promoters and 62.21% by Public. <p align=justify> Top five Promoters holding highest number of shares of Sa

  • Sandu Pharma. - Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders

    11 Jul 2026, 5:37PM Reconstitution of Committees of Board-Audit/Nomination/Stakeholders

  • Sandu Pharma. - Announcement under Regulation 30 (LODR)-Change in Directorate

    11 Jul 2026, 5:33PM 1.Appointment of Dr Neeti Madan Kapre (DIN:06801264) as additional Non Executive Independent Director of the Company\r\n2.Redesignation of Shri Balram

  • Sandu Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.07.2026

    11 Jul 2026, 5:29PM Outcome of the Board Meeting dated 11.07.2026

  • Sandu Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 4:10PM Certificate under Regulation 74(5) of SEBI(DP) Regulation

  • Sandu Pharma. - Board Meeting Intimation for To Place On Record The Demise Of Shri Umesh B. Sandu(DIN:01132141), Managing Dir

    6 Jul 2026, 10:48AM Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to conside

  • Sandu Pharma. - Announcement under Regulation 30 (LODR)-Change in Directorate

    19 Jun 2026, 4:22PM Sad demise of Shri Umesh Sandu (DIN:01132141) Managing Director of the company

  • Sandu Pharma. - Announcement under Regulation 30 (LODR)-Cessation

    19 Jun 2026, 3:36PM sad demise of Shri Umesh Sandu as Managing Director(DIN:01132141)

  • Sandu Pharma. - Announcement under Regulation 30 (LODR)-Demise

    19 Jun 2026, 3:22PM Intimation about sad demise of our Managing Director ,Shri Umesh Sandu(DIN:01132141)
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Sandu Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 43.6734 42.0172 40.5953 39.2444 36.4746
Liabilities 43.6734 42.0172 40.5953 39.2444 36.4746
Equity 9.661 9.661 9.661 9.661 8.8107
Gross Profit 3.0002 2.7622 2.2973 2.4893 2.874
Net Profit 1.7662 1.5489 1.4606 1.5239 1.5893
Cash From Operating Activities 6.1155 0.9504 0.7614 0.2212 0.9487
NPM(%) 2.52 2.3 2.17 2.33 2.42
Revenue 69.9345 67.1924 67.2807 65.349 65.5005
Expenses 66.9343 64.4302 64.9834 62.8597 62.6265
ROE(%) 4.02 3.52 3.32 3.47 3.62

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sandu Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 874.00 0.44 22.05 21.87 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 109.05 0.05 1542.57 79.69 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.55 -0.26 0.00 165.47 -39.50 0.00
Astec Lifesciences Ltd 572.25 1.05 0.00 85.39 -363.14 0.00

Company Info

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

Parent Organisation

Sandu Pharmaceuticals Ltd.

Founded

15/11/1985

Managing Director

NSE Symbol

FAQ